Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929159 · ClinicalTrials.gov registry record
Correlating MicroRNA Changes With Sepsis Outcomes
A clinical trial of Septicemia, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT03929159 is a study of Septicemia that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03929159, a study of Septicemia, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how changes in microRNAs may correlate with sepsis outcomes. Sepsis is a type of severe infection of the blood stream, and its diagnosis may be obscured by many other conditions such as surgery, trauma, and cancer. MicroRNAs are biomarkers found in the blood and tissue. Blood samples may help correlate changes in microRNA expression to patient reactions to a sepsis infection.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03929159
The ClinicalTrials.gov registry entry for NCT03929159 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Septicemia appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT03929159 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03929159 about?
NCT03929159 is a clinical study titled "Correlating MicroRNA Changes With Sepsis Outcomes". This trial studies how changes in microRNAs may correlate with sepsis outcomes. Sepsis is a type of severe infection of the blood stream, and its diagnosis may be obscured by many other conditions such as surgery, trauma, and cancer. MicroRNAs are biomarkers found in the blood and tissue. Blood samp...
What is the current status of trial NCT03929159?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2019-03-26. Estimated completion is 2026-12-31.
What conditions does trial NCT03929159 study?
This clinical trial studies the following conditions: Septicemia.
What interventions are being tested in trial NCT03929159?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT03929159?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03929159 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Septicemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.